Top compounds associated with response to LILRA2


Feature Type Standardized
Nominal ANOVA
mRNA PF-184 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA nelarabine CTRPv2 pan-cancer AAC 0.015 0.7
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.021 0.7
mRNA MS-275 gCSI pan-cancer AAC -0.025 0.7
mRNA CBB-1007 CTRPv2 pan-cancer AAC 0.021 0.7
mRNA prima-1 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA CHM-1 CTRPv2 pan-cancer AAC 0.012 0.7
mRNA ML312 CTRPv2 pan-cancer AAC 0.026 0.7
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.013 0.7
Download CSV